April 24, 2018

Theratechnologies to Seek Regulatory Approval of TrogarzoTM in Europe

Theratechnologies Inc. (Theratechnologies) (TSX:TH) today announced that it will seek regulatory approval from the European Medicines Agency (EMA) for TrogarzoTM using efficacy and safety data from the clinical trials submitted to the U.S. Food and Drug Administration (FDA).